{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "A30P, A53T, and E46K are missense mutations in SNCA associated with familial Parkinson's disease."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005308"
  },
  "Experiment Method": [
    {
      "Assay Method": "MTT assay (cell viability measurement)",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y (example, not explicitly stated in the text)",
        "Description": "The study used cell lines (e.g., SH-SY5Y) exposed to toxins like MPP+ to assess neuroprotection."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced neuroprotection compared to wild-type",
          "Result Description": "Mutant variants (A30P, A53T, E46K) showed decreased viability in MPP+-exposed cells compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed (implied by the experimental design)."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate for the MTT assay."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type cells were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Untreated cells or cells without MPP+ were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}